Related Experiment Video
Updated: Mar 29, 2026
Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
Post-COVID-19 Burden of Severe Influenza in England Among Overall Population and High-Risk Groups: Results From the
Wilhelmine Meeraus1, Lucy Carty2, Sabada Dube3
1Medical Evidence, Vaccines & Immune Therapies, AstraZeneca, Eastbrook House, Shaftesbury Road, Cambridge, CB2 8DU, UK. wilhelmine.meeraus@astrazeneca.com.
Introduction:
We describe the burden of severe influenza in England overall, and in risk groups (as defined by age, immunocompromise, and other comorbidities) and those with recent COVID-19.
Methods:
The INFORM (INvestigation oF cOvid-19 Risk among iMmunocompromised populations) cohort uses pseudonymised, routinely collected electronic health records of individuals aged ≥ 12 years from a random 25% sample of England's population (N = 12.1 million). In this analysis, during 1 July 2022 to 30 June 2023, crude incidence rates (IRs) and age- and sex-adjusted IR ratios were estimated for severe influenza outcomes of hospitalisation, intensive care unit (ICU) admission and death. The analyses were repeated for outcomes of severe influenza with recent COVID-19 (< 6 months).
Results:
The analysis sample comprised 12,075,920 individuals aged ≥ 12 years; 3.9% were immunocompromised. Overall, IRs of severe influenza were 10.51 (hospitalisations), 0.35 (ICU admissions) and 0.73 (deaths) per 10,000 person-years. Of those with influenza hospitalisation, 13.1% had recent COVID-19. Overall, influenza hospitalisation IRs per 10,000 person-years increased with advancing age, from 3.56 for adolescents aged 12-17 years to 58.43 for adults aged ≥ 80 years. Compared with other age groups, among hospitalised individuals, the highest intensity of management occurred in adolescents aged 12-17 years, based on the proportion of influenza hospitalisations that involved ICU admission (6.2%) or mechanical ventilation (3.0%) in this age group. Increased age- and sex-adjusted risk of severe influenza outcomes was observed among individuals with immunocompromise and other comorbidities.
Conclusions:
Seasonal severe influenza was observed in the general population aged ≥ 12 years in England in 2022-2023, with a disproportionately higher burden recorded in risk groups (as defined by age, immunocompromise, recent COVID-19 and other comorbidities). These data reinforce continued efforts to immunise individuals against seasonal influenza.
Trial Registration:
International Standard Randomised Controlled Trial Number Registry: ISRCTN53375662.
More Related Videos
Related Concept Videos
01:27Influenza
01:28Infectious Diseases and Their Occurrence
01:51Vaccinations
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:30Inhibitors of Viral Protein Synthesis